ghk cu peptide injection for hair GHK-Cu Topical vs GHK-Cu Injection Redness & Welting

On the therapeutic side, a Phase 1 clinical trial investigated MVT-602 a kisspeptin receptor agonist in women with PMOS and hypothalamic amenorrhea

GHK-Cus 300+ peer-reviewed publications, including multiple genomic studies and wound healing trials, provide a stronger evidentiary foundation than Matrixyls primarily cosmetic trial record

By month3-6, increased libido, lean muscle mass, additional 5-10% weight loss when added to other injectable weight loss medication, more belly fat reduction, etc

However, we prefer subcutaneous administration over intramuscular injection, especially for frequent self-injection